09/02/2019 03:50:00

IMMUNOMEDICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Immunomedics, Inc. - IMMU

NEW ORLEANS, Feb. 08, 2019 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until February 25, 2019 to file lead plaintiff applications in a securities class action lawsuit against Immunomedics, Inc. (NasdaqGM: IMMU), if they purchased the Company’s shares between August 23, 2018 and December 20, 2018, inclusive (the “Class Period”).  This action is pending in the United States District Court for the District of New Jersey.

What You May Do

If you purchased shares of Immunomedics and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email (lewis.kahn@ksfcounsel.com), or visit https://www.ksfcounsel.com/cases/nasdaql-immu/ to learn more. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by February 25, 2019.

About the Lawsuit

Immunomedics and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws. 

On December 17, 2018, FDAnews.com reported in an article entitled “FDA Hits Immunomedics for Data Integrity Breach” that “the FDA cited Immunomedics for a host of violations-including its handling of a data integrity breach-observed at its Morris Plains, New Jersey, drug substance manufacturing facility between August 6 and 14.” Then, on December 20, 2018, Favus Institutional Research issued a report further detailing the breach.

On this news, the price of Immunomedics’ shares plummeted.

The case is Odeh v. Immunomedics, Inc. et al., No. 2:18-cv-17645.

About Kahn Swick & Foti, LLC

KSF, whose partners include the former Louisiana Attorney General Charles C. Foti, Jr., is a law firm focused on securities, antitrust and consumer class actions, along with merger & acquisition and breach of fiduciary litigation against publicly traded companies on behalf of shareholders. The firm has offices in New York, California and Louisiana.

To learn more about KSF, you may visit www.ksfcounsel.com.

Contact:

Kahn Swick & Foti, LLC

Lewis Kahn, Managing Partner

lewis.kahn@ksfcounsel.com

1-877-515-1850

1100 Poydras St., Suite 3200

New Orleans, LA 70163

Logo -Color.jpg

Related content
08 Apr - 
Immunomedics Announces Promotion Agreement With Janssen..
07 Mar - 
Immunomedics Appoints Barbara G. Duncan to Board of Dir..
04 Mar - 
Immunomedics to Participate in Cowen and Company 39th A..
Del

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
HQDA Acquires 51% of Palua Airline and Tourism Companies
2
Upper Street Marketing Inc. Announces Strategic Partnership in Canada
3
Bragar Eagel & Squire, P.C. is Investigating Lyft, Inc. (LYFT) on Behalf of Stockholders and Encourages LYFT Investors to Contact the Firm
4
American Indian College Fund Celebrates 30 Years of Service to Native Americans Pursuing Higher Education
5
Oak Valley Bancorp Reports 1st Quarter Results

Related stock quotes

Immunomedics Inc 16.99 2.0% Stock price increasing

Latest news


Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
19 April 2019 10:10:37
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190410.2 - EUROWEB7 - 2019-04-19 11:10:37 - 2019-04-19 10:10:37 - 1000 - Website: OKAY